La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Lucas GC a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Lucas GC..

Lucas GC (NASDAQ:LGCL) Azioni, Catena delle Opzioni

Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China. Its business segments consist of recruitment services, outsourcing services, and other services, which include information technology services and training services.

Lucas GC Ltd

WIIM

Dine Brands Global shares are trading higher after Barclays raised its price target on the stock from $21 to $24.

UBS analyst Roger Boyd maintains Fortinet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) with a Neutral and lowers the price target from $115 to $105.

News

Price Target

Analyst Ratings

FTNT

UBS Maintains Neutral on Fortinet, Lowers Price Target to $105

RBC Capital analyst Arun Viswanathan maintains Chemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CC#NYSE">CC</a>) with a Outperform and lowers the price target from $17 to $14.

RBC Capital Maintains Outperform on Chemours, Lowers Price Target to $14

Capital Allocation and Dividend Policy
As previously announced, the Company continues to evaluate opportunities to refranchise certain international markets including Australia and New Zealand, Japan, Mexico, and the U.K. and Ireland.
Following a review of the Company's capital allocation strategy and investments available to fuel our growth, the Company has made the decision to no longer pay quarterly cash dividends to holders of the Company's common stock. This decision provides greater financial flexibility, enabling debt paydown and a focus on profitable, high return growth.

Dividends

DNUT

Krispy Kreme Halts Quarterly Dividend Payments

UBS analyst Lu Li maintains Veracyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCYT#NASDAQ">VCYT</a>) with a Buy and lowers the price target from $49 to $42.

VCYT

UBS Maintains Buy on Veracyte, Lowers Price Target to $42

RBC Capital analyst Elvira Scotto maintains Targa Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRGP#NYSE">TRGP</a>) with a Outperform and lowers the price target from $199 to $191.

TRGP

RBC Capital Maintains Outperform on Targa Resources, Lowers Price Target to $191

BrightView Holdings shares are trading higher after the company reported better-than-expected Q2 financial results.

<a href="https://www.bloomberg.com/news/articles/2025-05-08/consumer-watchdog-halts-biden-era-google-payment-supervision">https://www.bloomberg.com/news/articles/2025-05-08/consumer-watchdog-halts-biden-era-google-payment-supervision</a>

General

GOOG

GOOGL

'Consumer Watchdog Halts Biden-Era Google Payment Supervision'- Bloomberg

Owens & Minor shares are trading lower after the company reported worse-than-expected Q1 sales results

UBS analyst William Appicelli maintains Vistra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) with a Buy and raises the price target from $154 to $160.

UBS Maintains Buy on Vistra, Raises Price Target to $160

Announces Intention to Withhold Votes for Directors Dr. Mary Ann Gray and Dr. Alpna Seth
AUSTIN, Texas, May 8, 2025 /PRNewswire/ --&nbsp;ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1"), the largest stockholder of Keros Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) ("Keros" or the "Company") with approximately 13.3% of the Company's outstanding shares, today released a public letter to fellow Keros stockholders outlining its concerns with the Company's capital allocation decisions, strategic direction, and prolonged underperformance.
&nbsp;
<a href="https://mma.prnewswire.com/media/2682832/ADAR1_Letter_to_Keros_Shareholders_05_08_2025.pdf?p=original">In the letter, ADAR1 details the Company's alarming clinical results for two of its three drug candidates — KER-012 and KER-065 — and expresses serious concern that continued investment in these programs risks further shareholder value destruction. ADAR1 calls for Keros to restructure the business, significantly reduce headcount, return excess capital to stockholders, and ensure the Takeda licensing partnership is managed to maximize value for investors.</a>
<a href="https://mma.prnewswire.com/media/2682832/ADAR1_Letter_to_Keros_Shareholders_05_08_2025.pdf?p=original">Given its loss of confidence in the Company's management and Board of Directors, ADAR1 announced its intention to "WITHHOLD" votes on the re-election of Dr. Mary Ann Gray and Dr. Alpna Seth at Keros' upcoming Annual Meeting of Stockholders, scheduled to be held on June 4, 2025.</a>

KROS

Keros' Largest Stockholder, ADAR1, Announces Intention to Withhold Votes for Directors Dr. Mary Ann Gray and Dr. Alpna Seth At The Upcoming Keros Annual Meeting Of Stockholders On June 4, 2025

UBS analyst Kunal Madhukar maintains Angi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGI#NASDAQ">ANGI</a>) with a Neutral and lowers the price target from $24 to $20.

ANGI

UBS Maintains Neutral on Angi, Lowers Price Target to $20

RBC Capital analyst Christopher Dendrinos maintains Sunrun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) with a Outperform and lowers the price target from $14 to $12.

RBC Capital Maintains Outperform on Sunrun, Lowers Price Target to $12

UBS analyst Jay Sole maintains Steven Madden (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOO#NASDAQ">SHOO</a>) with a Neutral and raises the price target from $22 to $23.

SHOO

UBS Maintains Neutral on Steven Madden, Raises Price Target to $23

RBC Capital analyst Matthew McKellar maintains Rayonier Adv Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) with a Outperform and lowers the price target from $9 to $6.

RYAM

RBC Capital Maintains Outperform on Rayonier Adv Materials, Lowers Price Target to $6

UBS analyst Taylor McGinnis maintains Amplitude (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPL#NASDAQ">AMPL</a>) with a Neutral and lowers the price target from $13 to $11.

AMPL

UBS Maintains Neutral on Amplitude, Lowers Price Target to $11

UBS analyst John Hodulik maintains Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a Buy and raises the price target from $105 to $120.

UBS Maintains Buy on Walt Disney, Raises Price Target to $120

UBS analyst Lloyd Walmsley maintains Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) with a Buy and raises the price target from $103 to $107.

UBER

UBS Maintains Buy on Uber Technologies, Raises Price Target to $107

RBC Capital analyst Daniel Perlin maintains Q2 Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QTWO#NYSE">QTWO</a>) with a Sector Perform and lowers the price target from $108 to $101.

QTWO

RBC Capital Maintains Sector Perform on Q2 Holdings, Lowers Price Target to $101

Match Group Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) stock dropped after the company reported <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/n45281924/match-group-announces-first-quarter-results" rel="noreferrer noopener">fiscal first-quarter</a> financial results on Thursday.
Total revenue declined 3% year-over-year to $831.2 million as payers fell 5% to 14.2 million. The analyst consensus estimate was $827.5 million.
GAAP EPS of $0.44 missed the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate</a> of $0.45.
Tinder revenue was down 7% Y/Y, while Hinge revenue increased 23% Y/Y.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43541039/match-group-divides-analysts-following-earnings-new-management-likely-to-be-well-received" rel="noreferrer noopener">Match Group Divides Analysts Following Earnings: New Management &#8216;Likely To Be Well Received&#8217;</a>
Revenue per Payer for the first quarter was $19.07, up 1% year-over-year. Tinder payers were 9.1 million, down 6%, and Hinge Payers were 1.7 million, up 19%.
Revenue for the Evergreen &amp; Emerging category fell 12% year over year, and Match Group Asia revenue declined 11% year over year.
The company generated operating cash flow of&nbsp;$193 million&nbsp;and free cash flow of&nbsp;$178 million during the quarter.
Match Group also announced a planned 13% <a target="_blank" href="https://ir.mtch.com/investor-relations/news-events/quarterly-results/default.aspx" rel="noreferrer noopener">workforce reduction to</a> accomplish $100 million in annualized savings, including approximately $45 million of in-year savings in 2025.
It also centralized key functions, including select technology and data services, customer care and content moderation, media buying, and international go-to-market functions.
Outlook: Match Group expects second-quarter revenue of $850 million-$860 million versus <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">analyst consensus estimate</a> of $846.71 million. The company reiterated <a target="_blank" href="https://www.benzinga.com/general/social-media/25/02/43482828/market-swipes-left-on-match-group-q4-earnings-ceo-breakup" rel="noreferrer noopener">full-year 2025 revenue</a> of $3.375 billion-$3.500 billion versus analyst consensus estimate of $3.444 billion.
Price Action:&nbsp;MTCH stock was down 7.47% to $28.11 at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/05/45209108/reddit-rallies-on-ad-surge-global-growth-analyst-upgrades-to-buy" target="_blank" rel="noreferrer noopener">Reddit Rallies On Ad Surge, Global Growth: Analyst Upgrades To Buy</a></li>
</ul>
Photo by Koshiro K via Shutterstock

Earnings

Guidance

Movers

Tech

MTCH

Investors Unmatch With Tinder Stock Following Q1 Performance

Press Releases

Lucas GC Limited Awarded The 2024 Most Valuable Brand for Investment

Lucas GC Limited to Announce a Strategic Partnership with Bank of Ningbo to Develop AI solutions to Enhance Wealth Management Business

Legal

Lucas GC Limited Received a Significant Invention Patent in Artificial Intelligence

Lucas GC and 4Paradigm Signed Strategic Cooperation Agreement to Develop Artificial Intelligence Training Program

Lucas GC Limited Signed a Strategic Agreement with Industrial Securities Co., Limited to Develop AI Solutions to Boost Productivity in Selling Financial Products

Comments

Lucas GC

Lucas GC (LGCL) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO